MedJ takes you straight to ASCO 2025.
Professor Linda Duska from the University of Virginia School of Medicine enthusiastically shared the KEYNOTE-A18 study, redefining the first-line treatment standard for advanced cervical cancer.
MedJ takes you straight to ASCO 2025.
Professor Linda Duska from the University of Virginia School of Medicine enthusiastically shared the KEYNOTE-A18 study, redefining the first-line treatment standard for advanced cervical cancer.